Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · IEX Real-Time Price · USD
3.550
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
3.440
-0.110 (-3.10%)
Pre-market: Jul 22, 2024, 8:25 AM EDT
Lisata Therapeutics Employees
Lisata Therapeutics had 25 employees as of December 31, 2023. The number of employees decreased by 2 or -7.41% compared to the previous year.
Employees
25
Change (1Y)
-2
Growth (1Y)
-7.41%
Revenue / Employee
n/a
Profits / Employee
-$802,160
Market Cap
29.49M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Rapid Micro Biosystems | 193 |
Evogene | 142 |
Pluri | 134 |
Enlivex Therapeutics | 71 |
Surrozen | 42 |
Daré Bioscience | 26 |
Lipocine | 17 |
bioAffinity Technologies | 14 |
LSTA News
- 4 days ago - Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy - GlobeNewsWire
- 6 days ago - Lisata Therapeutics Announces Completion of Enrollment in its Phase 2a BOLSTER Trial of Certepetide in First-Line Cholangiocarcinoma - GlobeNewsWire
- 12 days ago - Lisata Therapeutics' Certepetide Shows Promise in Improving Standard Treatment for Intrahepatic Cholangiocarcinoma in a Preclinical Model - GlobeNewsWire
- 5 weeks ago - Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial - GlobeNewsWire
- 7 weeks ago - Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor Events - GlobeNewsWire
- 2 months ago - Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic Cancer - GlobeNewsWire
- 2 months ago - Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Lisata Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update on Thursday, May 9, 2024 - GlobeNewsWire